Xiaoxia Yu
107 Yanjiang West Road
Guangzhou, 510120, China
Guangzhou, 510120, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Development of a real-world, therapeutic drug monitoring-informed model to predict teicoplanin daily dose in pediatric intensive care unit patients with bacterial infections.
Journal: International journal of clinical pharmacy
Published: January 06, 2026
The Influence of Dexmedetomidine Added to Ropivacaine on Its Pharmacokinetic and Pharmacodynamic Effects During Lumbar Plexus Block.
Journal: Anesthesia and analgesia
Published: December 04, 2025
EcoRxAgent: an AI agent for generating economically substitutable prescriptions.
Journal: NPJ digital medicine
Published: October 15, 2025
Population Pharmacokinetics of Busulfan in Pediatric Patients: Optimization of a Four-Times-Daily Dosing Regimen Based on EBMT Recommendations.
Journal: Pediatric blood & cancer
Published: June 12, 2025
Risk of Ophthalmotoxicity Associated with Antibody-Drug Conjugates: A Systematic Review and Meta-analysis.
Journal: Clinical drug investigation
Published: April 24, 2025
Machine learning based obesity and aging related signature for predicting the prognosis and immunotherapy benefit in stomach adenocarcinoma.
Journal: Discover oncology
Published: February 01, 2025
Hemorrhage profile associated with immune checkpoint inhibitors: a systematic review and a real-world study based on the FAERS database.
Journal: Expert opinion on drug safety
Published: April 01, 2024
Physiologically-based pharmacokinetic modelling to investigate the effect of CYP3A4/3A5 maturation on tacrolimus pharmacokinetics in paediatric HSCT patients.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: September 27, 2023
A polymeric nanocarrier that eradicates breast cancer stem cells and delivers chemotherapeutic drugs.
Journal: Biomaterials research
Published: September 19, 2023
Thromboembolism profiles associated with cyclin-dependent kinase 4/6 inhibitors: a real-world pharmacovigilance study and a systematic review.
Journal: Expert opinion on drug safety
Published: February 16, 2023
A pharmacovigilance analysis of FDA adverse event reporting system events for romosozumab.
Journal: Expert opinion on drug safety
Published: September 30, 2022
Immune checkpoint inhibitors increase the risk of kidney transplant rejection: a real-world pharmacovigilance study.
Journal: Expert opinion on drug safety
Published: August 05, 2022
Last Updated: 09/26/2026